dexamethasone,lenalidomide,bortezomib
takeda
['multiplemyeloma', 'determination']
improved progression-free survival in pts with #multiplemyeloma following 3-drug therapy with autologous stem cell transplant: determination clarifies benefits and risks of treatment options. paul richardson, md, presents in plenary session at #asco22. 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090